OTUB1 and neoplasm: And IHC staining of OTUB1, KI67, RACK1, p-ERK, p-AKT, and p-FAK supported that efficient OTUB1 knockdown ameliorated the hyperactivation of the oncogenic pathway (Fig. 3f, g), and corroborated the reduced subcutaneous tumor growth when OTUB1 silenced.